Hemant Surgical Industries Ltd
₹0.00▲ +0.00 (+0.00%)
HEMANTSURGICALINDUSTRIESLTD·NSE·Healthcare
Market Cap
654.16 Cr
PE Ratio
36.90
Volume
—
Day High - Low
—
52W High-Low
497.00 - 215.00
₹0.00▲ +0.00 (+0.00%)
Market Cap654.16 Cr
PE Ratio36.90
Volume—
Day High - Low—
52W High-Low497.00 - 215.00
Hemant Surgical Industries Ltd (HEMANTSURGICALINDUSTRIESLTD): company summary
Hemant Surgical Industries Ltd (HEMANTSURGICALINDUSTRIESLTD) is a micro-cap Healthcare company valued at ₹654 crore operating in Medical Equipment on the NSE and BSE.
Hemant Surgical Industries Ltd (HEMANTSURGICALINDUSTRIESLTD) is a micro-cap Healthcare company valued at ₹654 crore operating in Medical Equipment on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 28.6% a year over three years; profit grew 34.2% a year, ahead of revenue — margins are expanding. Return on equity is 18.2%.
- Valuation multiples
- The stock trades at 36.9 times earnings, a premium to the Healthcare median of 32.0, 4.01 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
18.20%
Strong
P/E
36.90x
Expensive
Debt / Equity
0.36
Moderate
Industry
Healthcare
Medical Equipment
Overall View
Mixed
Price performance
52W₹215.00
₹497.00
DocStoX take
Supported by growth (8.5), but held back by valuation (1.2). Growth looks strong at 8.5, but that is offset by valuation at 1.2. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.6
/10
Weak
Quality
Modest
ROE 18.2%
Valuation
Expensive
P/E 36.9×
Growth
Strong
Revenue +31.0% 5Y CAGR
Risk
Elevated
D/E 0.36
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹654 Cr
52W High / Low
₹497 / ₹215
Dividend Yield
0.00%
Promoter Holding
52.83%
EPS (TTM)
₹7.79
Book Value
₹115.00
Key highlights
- Profit compounding 81% a year
- Revenue compounding 31% a year
- Profitable in all of the last 5 years
- Valuation is weak (1.2/10)
- Small ₹654 cr company — thinner liquidity
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment
Explore Hemant Surgical Industries Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Hemant Surgical Industries Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Hemant Surgical Industries Ltd with peers
Hemant Surgical Industries Ltd vs Sun Pharmaceutical Industries LimitedHemant Surgical Industries Ltd vs Divi's Laboratories LimitedHemant Surgical Industries Ltd vs Torrent Pharmaceuticals LimitedHemant Surgical Industries Ltd vs Apollo Hospitals Enterprise LimitedHemant Surgical Industries Ltd vs Zydus Lifesciences LimitedHemant Surgical Industries Ltd vs Laurus Labs Limited
Related tools & concepts
Value Hemant Surgical Industries Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing